-

Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

LOS ANGELES--(BUSINESS WIRE)--Caldera Medical, a women’s health medical device company that develops and markets best-in-class products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps and Fibroids, announced today that it has completed its acquisition of Atlantic Therapeutics, an Ireland based provider of non-invasive pelvic floor strengthening and nerve stimulating solutions for women. The acquisition bolsters Caldera Medical’s expanding portfolio, furthering its mission to improve the quality of life for women!

By acquiring Atlantic Therapeutics, Caldera Medical adds the commercial leading non-invasive, FDA cleared, Innovo product family as a first-line therapy for women with stress urinary incontinence. Caldera Medical will maintain a European headquarters and innovation center in Galway, Ireland.

"We are thrilled to acquire Atlantic Therapeutics and scale the rapidly growing Innovo products worldwide," said Bryon Merade, CEO of Caldera Medical, "This acquisition aligns perfectly with our mission and allows us to offer an even more comprehensive suite of solutions to healthcare providers and patients alike."

“Since its formation, the team at Atlantic Therapeutics has demonstrated the huge potential of Innovo,” commented Susan Trent, CEO of Atlantic Therapeutics, “This unique technology with robust clinical data is ideally placed to serve the millions of women worldwide who suffer the daily distress of SUI. Caldera Medical’s ability to maximize this potential is the perfect next step. I am delighted that we will see Innovo thrive within Caldera Medical and want to thank Bryon and the team for their dedication to women’s health.”

About Caldera Medical

Caldera Medical is a medical device company solely focused on women’s health with a commitment to our mission of “Improving the Quality of Life for Women!” Caldera Medical develops, manufactures and markets best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse Polyps and Fibroids.

Caldera Medical forms close relationships with surgeons and continues to build the company around a principle of customer intimacy. In partnership with its surgeon customers, Caldera Medical has the largest humanitarian program of any women’s health company. It is committed to treating one million women in underserved populations around the world by the year 2027.

About Atlantic Therapeutics

Atlantic Therapeutics, based in Ireland, specializes in the development of medical devices, related software, and connected health technologies. The company primarily treats incontinence, sexual health dysfunctions, and other related disorders. They produce pelvic floor strengthening devices and nerve stimulation products, all of which are supported by robust clinical evidence and have undergone randomized controlled trials. Healthcare professionals worldwide depend on Atlantic Therapeutics' solutions to enhance the lives of tens of thousands of patients annually.

Contacts

Caldera Medical Media Relations
Katrina Owens - pr@calderamedical.com

Caldera Medical


Release Summary
Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

Contacts

Caldera Medical Media Relations
Katrina Owens - pr@calderamedical.com

Social Media Profiles
More News From Caldera Medical

Caldera Medical Acquires Ethicon’s GYNECARE TVT™ Family of Products in Transformational Expansion Globally for Women’s Health Company

LOS ANGELES--(BUSINESS WIRE)--Caldera Medical, a leader in women's health medical devices, has acquired Ethicon’s Gynecare TVT™ family of products and will transition the products in the coming months. This strategic milestone builds on Caldera Medical’s 23-year commitment to delivering best-in-class therapies that improve the quality of life for women worldwide. The TVT product line - consisting of TVT, TVT Exact, TVT-O and TVT Abbrevo, provides minimally invasive treatment options for women w...

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

LOS ANGELES--(BUSINESS WIRE)--Caldera Medical, a leader in women's health medical devices, announced today the acquisition of UVision 360, Inc., the developer of the LUMINELLE® hysteroscopy and cystoscopy systems. This strategic acquisition bolsters Caldera Medical’s minimally invasive solutions, particularly in the realm of advanced hysteroscopy, broadening its portfolio for the diagnosis and treatment of conditions such as polyps, fibroids, and intrauterine pathology. "We are excited to integ...

Caldera Medical Announces Sponsorship of Cynisca Cycling Team to Champion Women's Health and Empowerment

LOS ANGELES--(BUSINESS WIRE)--Caldera Medical, a global leader in women’s pelvic health, is proud to announce its sponsorship of the Cynisca Cycling team. This partnership reflects Caldera Medical’s unwavering commitment to advancing women’s health and empowerment through sports and community engagement. Cynisca Cycling, an elite women's professional cycling team, is dedicated to elevating female athletes and promoting gender equality in sports. The collaboration with Caldera Medical, renowned...
Back to Newsroom